He has served as the scientific advisor to several television shows (including Westworld and Perception) and has been profiled on the Colbert Report, NOVA Science Now, the New Yorker, CNN’s Next List, and many other venues. He serves as the academic editor for the Journal of Science and Law, was named Science Educator of the Year by the Society for Neuroscience, and was featured as one of the Brightest Idea Guys by Italy’s Style magazine. He is the Chief Scientific Advisor for the Mind Science Foundation and the winner of the Claude Shannon Luminary Award from Bell Labs and the McGovern Award for Excellence in Biomedical Communication. The Runaway Species, co-authored with music composer Anthony Brandt, explores the neuroscience and behavior behind human creativity.Įagleman is a TED speaker, a Guggenheim Fellow, and serves on several boards, including the American Brain Foundation and the The Long Now Foundation. The award-winning Wednesday is Indigo Blue explores the neurological condition of synesthesia, in which the senses are blended. The Safety Net examines what the advent of the internet means on the timescale of civilizations.

His work of fiction, SUM, is an international bestseller published in 33 languages and turned into two operas. His bestselling book Incognito: The Secret Lives of the Brain, explores the neuroscience “under the hood” of the conscious mind: all the aspects of neural function to which we have no awareness or access.

His latest book Livewired tells the story of brain plasticity: how your forest of billions of neurons reconfigures every moment over your life. Kim received her Executive MBA at the University of Southern California Marshall School of Business and BS in Management from Pepperdine University.Beyond his 120+ academic publications, he has published many popular books. by Stryker Neurovascular), Guidant Corporation (acq. by Balt International), Concentric Medical (acq. She has held senior leadership positions at Johnson & Johnson, Blockade Medical (acq.

Previously, Kim was CEO at Halt Medical and led the largest business unit, Vascular Intervention, at Spectranetics (acq. Under her leadership, the company raised $30M, launched a new product, obtained broad insurance coverage, and was acquired by Hologic for over $120M in upfront and expected follow-on payments. Earlier, she served as CEO & Co-Founder of Acessa Health-a venture-backed startup providing a minimally-invasive, uterine-sparing fibroid treatment for women. Most recently, as a Venture Partner at S3 Ventures, she supported the firm’s healthcare investments. Kim Rodriguez has 25 years of global healthcare and medical device industry experience, spanning multiple therapeutic areas-including neurology, cardiology, and women’s health.

The brain with dr david eagleman